Calmoseptine Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Calmoseptine is the best-performing calmoseptine brand in July 2026, moving 25,500 units across 9 ASINs for 96.2% of Top 10 volume. TriDerma follows with 1,000 units (3.8%).

With 2 brands splitting the Top 10 and 100.0% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $19.67 to $24.99, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, 2 ASINs forced its way in: B005239XLM booked 500 units at $8.90, with ▲ 66.7% MoM change. On the growth side, B01M3YQZZB leads positive momentum with ▲ 100.0% MoM growth on 200 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.